Jennifer Burgher Seaman1, Lauren Terhorst2,3, Amanda Gentry3, Amanda Hunsaker4,5, Lisa S Parker6, Jennifer Hagerty Lingler3,5. 1. University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA. 2. University of Pittsburgh School of Health and Rehabilitation Sciences, Pittsburgh, PA, USA. 3. University of Pittsburgh School of Nursing, Pittsburgh, PA, USA. 4. University of Pittsburgh School of Social Work, Pittsburgh, PA, USA. 5. University of Pittsburgh, School of Medicine Alzheimer Disease Research Center (ADRC), Pittsburgh, PA, USA. 6. University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA.
Abstract
BACKGROUND: With the growing population of individuals affected by Alzheimer's disease (AD) and related disorders, there is a pressing demand for research on late-life cognitive disorders. However, this population's high risk for decisional incapacity necessitates evaluation of capacity to consent to research participation, adding cost and complexity to the research process. The University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) was initially validated in a sample of persons with schizophrenia and healthy controls. OBJECTIVE: To assess the psychometric properties of the UBACC when used in a sample of individuals contemplating participation in AD research. METHODS: The UBACC was administered to a convenience sample (n = 132) consisting of individuals with mild to moderate cognitive impairment (n = 52), their study partners (n = 52), and healthy older adults control subjects (n = 30), as part of a broader study to evaluate perceived burden of research participation. Reliability tests, correlational analyses, and exploratory factor analytic methods were used to examine the psychometric properties of the instrument. RESULTS: UBACC scores were significantly associated with both global cognition (rs= 0.564, p < 0.001) and verbal fluency (rs = 0.511, p < 0.001), indicating concurrent validity with related constructs. The resulting factor structure differed from that reported by the developers in their initial testing. Items clustered almost entirely on one factor; items reflecting the construct of understanding accounted for 32.12% of total variance, with no evidence for distinct reasoning or appreciation scales. CONCLUSION: The UBACC shows promise when used to screen for decisional capacity among those considering participation in AD research.
BACKGROUND: With the growing population of individuals affected by Alzheimer's disease (AD) and related disorders, there is a pressing demand for research on late-life cognitive disorders. However, this population's high risk for decisional incapacity necessitates evaluation of capacity to consent to research participation, adding cost and complexity to the research process. The University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) was initially validated in a sample of persons with schizophrenia and healthy controls. OBJECTIVE: To assess the psychometric properties of the UBACC when used in a sample of individuals contemplating participation in AD research. METHODS: The UBACC was administered to a convenience sample (n = 132) consisting of individuals with mild to moderate cognitive impairment (n = 52), their study partners (n = 52), and healthy older adults control subjects (n = 30), as part of a broader study to evaluate perceived burden of research participation. Reliability tests, correlational analyses, and exploratory factor analytic methods were used to examine the psychometric properties of the instrument. RESULTS: UBACC scores were significantly associated with both global cognition (rs= 0.564, p < 0.001) and verbal fluency (rs = 0.511, p < 0.001), indicating concurrent validity with related constructs. The resulting factor structure differed from that reported by the developers in their initial testing. Items clustered almost entirely on one factor; items reflecting the construct of understanding accounted for 32.12% of total variance, with no evidence for distinct reasoning or appreciation scales. CONCLUSION: The UBACC shows promise when used to screen for decisional capacity among those considering participation in AD research.
Authors: O L Lopez; J T Becker; W Klunk; J Saxton; R L Hamilton; D I Kaufer; R A Sweet; C Cidis Meltzer; S Wisniewski; M I Kamboh; S T DeKosky Journal: Neurology Date: 2000-12-26 Impact factor: 9.910
Authors: Dilip V Jeste; Barton W Palmer; Paul S Appelbaum; Shahrokh Golshan; Danielle Glorioso; Laura B Dunn; Kathleen Kim; Thomas Meeks; Helena C Kraemer Journal: Arch Gen Psychiatry Date: 2007-08
Authors: Mark A Hall; Fabian Camacho; Janice S Lawlor; Venita Depuy; Jeremy Sugarman; Kevin Weinfurt Journal: Med Care Date: 2006-11 Impact factor: 2.983
Authors: Jennifer H Lingler; Karen L Schmidt; Amanda L Gentry; Lu Hu; Lauren A Terhorst Journal: J Empir Res Hum Res Ethics Date: 2014-10 Impact factor: 1.742
Authors: Oscar L Lopez; William J Jagust; Steven T DeKosky; James T Becker; Annette Fitzpatrick; Corinne Dulberg; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller Journal: Arch Neurol Date: 2003-10
Authors: Angela L Jefferson; Susan Lambe; David J Moser; Laura K Byerly; Al Ozonoff; Jason H Karlawish Journal: J Am Geriatr Soc Date: 2008-05-12 Impact factor: 5.562
Authors: Mengchi Li; Hyejin Kim; Susan M Sereika; Trevor J Nissley; Jennifer H Lingler Journal: Res Gerontol Nurs Date: 2022-02-11 Impact factor: 1.643
Authors: Rachel K B Hamilton; Cynthia H Phelan; Nathaniel A Chin; Mary F Wyman; Nickolas Lambrou; Nichelle Cobb; Amy J H Kind; Hanna Blazel; Sanjay Asthana; Carey E Gleason Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Megan M Campbell; Ezra Susser; Sumaya Mall; Sibonile G Mqulwana; Michael M Mndini; Odwa A Ntola; Mohamed Nagdee; Zukiswa Zingela; Stephanus Van Wyk; Dan J Stein Journal: PLoS One Date: 2017-11-29 Impact factor: 3.240
Authors: Jennifer H Lingler; J Scott Roberts; Hyejin Kim; Jonna L Morris; Lu Hu; Meghan Mattos; Eric McDade; Oscar L Lopez Journal: Alzheimers Dement (Amst) Date: 2018-05-30